Literature DB >> 27018286

Atopic dermatitis in older adults: A viewpoint from geriatric dermatology.

Ryoji Tanei1, Yasuko Hasegawa2.   

Abstract

Atopic dermatitis (AD) in older adults represents a newly defined subgroup of AD. The prevalence of elderly AD is approximately 1-3% among elderly populations in industrialized countries. Elderly patients with AD show some common clinical characteristics, such as a male predominance, a lower incidence of lichenified eczema at the elbow and knee folds, and particular patterns of onset and clinical course. Both immunoglobulin (Ig)E-allergic and non-IgE-allergic types are observed in elderly AD. Elderly patients with IgE-allergic AD show high rates of positivity for specific IgE antibodies against house dust mites, associations with IgE allergic and asthmatic complications, histopathological features with a predominance of IgE-mediated allergic inflammation in the lesional skin, and a significantly lower incidence of malignancy as compared with control subjects. The etiology of elderly AD might be associated with immunosenescence, age-related changes to the sex hormone milieu, age-related barrier dysfunctions in the skin and gut, functional disturbance of sweat production, and environmental stimuli in the lifestyle of elderly individuals. Powerful anti-inflammatory treatments, such as oral corticosteroids, might be required together with standard treatments to manage moderate to severe cases of elderly AD. Finally, most elderly patients with AD reach the end of life with this disease, which should now be considered a lifelong allergic disease.
© 2016 Japan Geriatrics Society.

Entities:  

Keywords:  clinical characteristics; immunoglobulin E; management; prognosis; skin manifestations

Mesh:

Year:  2016        PMID: 27018286     DOI: 10.1111/ggi.12771

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  15 in total

Review 1.  Working Up a Good Sweat - The Challenges of Standardising Sweat Collection for Metabolomics Analysis.

Authors:  Joy N Hussain; Nitin Mantri; Marc M Cohen
Journal:  Clin Biochem Rev       Date:  2017-02

Review 2.  Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis.

Authors:  Ryoji Tanei; Yasuko Hasegawa
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

3.  A Case of Papuloerythroderma Successfully Treated with Dupilumab.

Authors:  Ayaka Mizuno; Koji Habe; Yoshiaki Matsushima; Makoto Kondo; Keiichi Yamanaka
Journal:  Case Rep Dermatol       Date:  2022-05-23

Review 4.  Allergy and Aging: An Old/New Emerging Health Issue.

Authors:  Massimo De Martinis; Maria Maddalena Sirufo; Lia Ginaldi
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

5.  Severe Atopic Dermatitis In Spain: A Real-Life Observational Study.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda; José C Armario-Hita
Journal:  Ther Clin Risk Manag       Date:  2019-12-02       Impact factor: 2.423

Review 6.  Immunological Aspects of Skin Aging in Atopic Dermatitis.

Authors:  Georgeta St Bocheva; Radomir M Slominski; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 7.  Atopic Dermatitis in Older Adults: A Review of Treatment Options.

Authors:  Ryoji Tanei
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

Review 8.  Aging-associated alterations in epidermal function and their clinical significance.

Authors:  Zhen Wang; Mao-Qiang Man; Tienan Li; Peter M Elias; Theodora M Mauro
Journal:  Aging (Albany NY)       Date:  2020-03-27       Impact factor: 5.682

Review 9.  Microbiomes other than the gut: inflammaging and age-related diseases.

Authors:  Aurelia Santoro; Jiangchao Zhao; Lu Wu; Ciriaco Carru; Elena Biagi; Claudio Franceschi
Journal:  Semin Immunopathol       Date:  2020-09-30       Impact factor: 9.623

10.  The epidemiology of eczema in children and adults in England: A population-based study using primary care data.

Authors:  Simon de Lusignan; Helen Alexander; Conor Broderick; John Dennis; Andrew McGovern; Claire Feeney; Carsten Flohr
Journal:  Clin Exp Allergy       Date:  2020-11-26       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.